J
Juan C. Castillo
Researcher at University of Córdoba (Spain)
Publications - 84
Citations - 1352
Juan C. Castillo is an academic researcher from University of Córdoba (Spain). The author has contributed to research in topics: Infective endocarditis & Endocarditis. The author has an hindex of 16, co-authored 74 publications receiving 1114 citations.
Papers
More filters
Journal ArticleDOI
Association Between Transcatheter Aortic Valve Replacement and Subsequent Infective Endocarditis and In-Hospital Death
Ander Regueiro,Axel Linke,Azeem Latib,Nikolaj Ihlemann,Marina Urena,Thomas Walther,Oliver Husser,Howard C. Herrmann,Luis Nombela-Franco,Asim N. Cheema,Hervé Le Breton,Stefan Stortecky,Samir R. Kapadia,Antonio L. Bartorelli,Jan Malte Sinning,Ignacio J. Amat-Santos,Antonio J. Muñoz-García,Stamatios Lerakis,Enrique Gutiérrez-Ibañes,Mohamed Abdel-Wahab,Didier Tchetche,Luca Testa,Hélène Eltchaninoff,Ugolino Livi,Juan C. Castillo,Hasan Jilaihawi,John G. Webb,Marco Barbanti,Susheel Kodali,Fabio Sandoli de Brito,Henrique Barbosa Ribeiro,Antonio Miceli,Claudia Fiorina,Guglielmo Mario Actis Dato,Francesco Rosato,Vicenç Serra,Jean Bernard Masson,Harindra C. Wijeysundera,José Armando Mangione,Maria Cristina Ferreira,Valter Correa Lima,Luiz A. Carvalho,Alexandre Abizaid,Marcos Antonio Marino,Vinicius Esteves,Julio Andrea,Francesco Giannini,David Messika-Zeitoun,Dominique Himbert,Won-Keun Kim,Costanza Pellegrini,Vincent Auffret,Fabian Nietlispach,Thomas Pilgrim,Eric Durand,John Lisko,Raj Makkar,Pedro A. Lemos,Martin B. Leon,Rishi Puri,Alberto San Roman,Alec Vahanian,Lars Søndergaard,Norman Mangner,Josep Rodés-Cabau +64 more
TL;DR: Among patients undergoing TAVR, younger age, male sex, history of diabetes mellitus, and moderate to severe residual aortic regurgitation were significantly associated with an increased risk of infective endocarditis.
Journal ArticleDOI
Infective Endocarditis After Transcatheter Aortic Valve Implantation Results From a Large Multicenter Registry
Ignacio J. Amat-Santos,David Messika-Zeitoun,Hélène Eltchaninoff,Samir R. Kapadia,Stamatios Lerakis,Asim N. Cheema,Enrique Gutiérrez-Ibañes,Antonio J. Muñoz-García,Manuel Pan,John G. Webb,Howard C. Herrmann,Susheel Kodali,Luis Nombela-Franco,Corrado Tamburino,Hasan Jilaihawi,Jean-Bernard Masson,Fabio Sandoli de Brito,Maria Cristina Ferreira,Valter Correa Lima,José Armando Mangione,Bernard Iung,Alec Vahanian,Eric Durand,E. Murat Tuzcu,Salim S. Hayek,Rocío Angulo-Llanos,Juan José Gómez-Doblas,Juan C. Castillo,Danny Dvir,Martin B. Leon,Eulogio García,Javier Cobiella,Isidre Vilacosta,Marco Barbanti,Raj Makkar,Henrique Barbosa Ribeiro,Marina Urena,Eric Dumont,Philippe Pibarot,Javier E. López,Alberto San Roman,Josep Rodés-Cabau +41 more
TL;DR: The most frequent causal microorganisms were coagulase-negative staphylococci (24%), followed by Staphylocus aureus (21%) and enterococci(21%), vegetables were present in 77% of patients as discussed by the authors.
Journal ArticleDOI
Long term outcome of infective endocarditis in patients who were not drug addicts : a 10 year study
Juan C. Castillo,M. Anguita,A Ramírez,J R Siles,F. Torres,Dolores Mesa,Franco M,Ignacio Muñoz,Manuel Concha,F. Valles +9 more
TL;DR: A high early surgery rate is related to good long term results and does not increase in-hospital mortality, however, medical treatment also offers favourable longterm results in cases of responsive infective endocarditis where poor prognostic factors are absent.
Journal ArticleDOI
Simple and complex stent strategies for bifurcated coronary arterial stenosis involving the side branch origin.
Manuel Pan,José Suárez de Lezo,Alfonso Medina,Miguel Romero,Enrique Hernández,José L. Segura,Joaquin Ruiz de Castroviejo,Djordje Pavlovic,Francisco Melián,A Ramírez,Juan C. Castillo +10 more
TL;DR: Complex techniques providing radical stent reconstruction of the bifurcation seems to provide no advantages over the simpler stent jail followed by ostial side branch balloon dilation.
Journal ArticleDOI
Effect of early treatment with ivabradine combined with beta-blockers versus beta-blockers alone in patients hospitalised with heart failure and reduced left ventricular ejection fraction (ETHIC-AHF): A randomised study.
Francisco Hidalgo,Manuel Anguita,Juan C. Castillo,Sara Rodríguez,Laura Pardo,Enrique Durán,José J. Sánchez,Carlos Ferreiro,Manuel Pan,Dolores Mesa,Mónica Delgado,Martín Ruiz +11 more
TL;DR: The early coadministration of ivabradine and beta-blockers during hospital admission for acute HFrEF is feasible and safe, and it produces a significant decrease in HR at 28days and at 4months after hospital discharge.